» Articles » PMID: 34632331

Pioneer Factors in Development and Cancer

Overview
Journal iScience
Publisher Cell Press
Date 2021 Oct 11
PMID 34632331
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Transcription factors (TFs) are essential mediators of epigenetic regulation and modifiers of penetrance. Studies from the past decades have revealed a sub-class of TF that is capable of remodeling closed chromatin states through targeting nucleosomal motifs. This pioneer factor (PF) class of chromatin remodeler is ATP independent in its roles in epigenetic initiation, with nucleosome-motif recognition and association with repressive chromatin regions. Increasing evidence suggests that the fundamental properties of PFs can be coopted in human cancers. We explore the role of PFs in the larger context of tissue-specific epigenetic regulation. Moreover, we highlight an emerging class of chimeric PF derived from translocation partners in human disease and PFs associated with rare tumors. In the age of site-directed genome editing and targeted protein degradation, increasing our understanding of PFs will provide access to next-generation therapy for human disease driven from altered transcriptional circuitry.

Citing Articles

Opening and changing: mammalian SWI/SNF complexes in organ development and carcinogenesis.

Abu Sailik F, Emerald B, Ansari S Open Biol. 2024; 14(10):240039.

PMID: 39471843 PMC: 11521604. DOI: 10.1098/rsob.240039.


Exploring the reciprocity between pioneer factors and development.

Freund M, Harrison M, Torres-Zelada E Development. 2024; 151(13).

PMID: 38958075 PMC: 11266817. DOI: 10.1242/dev.201921.


Biological and therapeutic insights from animal modeling of fusion-driven pediatric soft tissue sarcomas.

Kucinski J, Calderon D, Kendall G Dis Model Mech. 2024; 17(6).

PMID: 38916046 PMC: 11225592. DOI: 10.1242/dmm.050704.


Pre-hypertrophic chondrogenic enhancer landscape of limb and axial skeleton development.

Darbellay F, Ramisch A, Lopez-Delisle L, Kosicki M, Rauseo A, Jouini Z Nat Commun. 2024; 15(1):4820.

PMID: 38844479 PMC: 11156918. DOI: 10.1038/s41467-024-49203-2.


E74-like ETS transcription factor 1 promotes the progression of pancreatic cancer by regulating doublecortin-like kinase 1/Janus kinase/signal transducer and activator of transcription pathway.

Yang B, Shen F, Zhu Y, Lu W, Cai H Am J Cancer Res. 2024; 14(2):616-629.

PMID: 38455425 PMC: 10915310.


References
1.
Pandey P, Chatterjee B, Olanich M, Khan J, Miettinen M, Hewitt S . PAX3-FOXO1 is essential for tumour initiation and maintenance but not recurrence in a human myoblast model of rhabdomyosarcoma. J Pathol. 2017; 241(5):626-637. PMC: 5357165. DOI: 10.1002/path.4867. View

2.
Kalashnikova A, Porter-Goff M, Muthurajan U, Luger K, Hansen J . The role of the nucleosome acidic patch in modulating higher order chromatin structure. J R Soc Interface. 2013; 10(82):20121022. PMC: 3627075. DOI: 10.1098/rsif.2012.1022. View

3.
Biegel J, Zhou J, RORKE L, Stenstrom C, Wainwright L, Fogelgren B . Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res. 1999; 59(1):74-9. View

4.
Magli A, Baik J, Mills L, Kwak I, Dillon B, Gonzalez R . Time-dependent Pax3-mediated chromatin remodeling and cooperation with Six4 and Tead2 specify the skeletal myogenic lineage in developing mesoderm. PLoS Biol. 2019; 17(2):e3000153. PMC: 6390996. DOI: 10.1371/journal.pbio.3000153. View

5.
Fu X, Pereira R, De Angelis C, Veeraraghavan J, Nanda S, Qin L . FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer. Proc Natl Acad Sci U S A. 2019; 116(52):26823-26834. PMC: 6936436. DOI: 10.1073/pnas.1911584116. View